DIAGNOSTIC VALUE OF FREE PROSTATE-SPECIFIC ANTIGEN AMONG MEN WITH PROSTATE-SPECIFIC ANTIGEN 2.0 TO 4.0NG/ML AT SCREENING COHORT IN JAPAN

被引：0
|
作者：
Sasaki, Mitsuharu
Ishidoya, Shigeto
Ito, Akihiro
Saito, Hideo
Shibuya, Daisuke
Arai, Yoichi
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.2074
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1917
引用
收藏
页码：E773 / E774
页数：2
相关论文
共 50 条
  • [1] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [2] Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL
    Fujizuka, Yuji
    Ito, Kazuto
    Oki, Ryo
    Suzuki, Rie
    Sekine, Yoshitaka
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (08) : 602 - 609
  • [3] Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population
    Kobayashi, T
    Nishizawa, K
    Mitsumori, K
    Ogura, K
    Ide, Y
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 478 - 479
  • [4] Editorial Comment to Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL
    Kitagawa, Yasuhide
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (08) : 609 - 610
  • [5] Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
    Morgentaler, Abraham
    Rhoden, Ernani Luis
    [J]. UROLOGY, 2006, 68 (06) : 1263 - 1267
  • [6] Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of &lt;3.0 μg per liter
    Finne, Patrik
    Auvinen, Anssi
    Maattanen, Liisa
    Tammela, Teuvo L.
    Ruutu, Mirja
    Juusela, Harri
    Martikainen, Paula
    Hakama, Matti
    Stenman, Ulf-Hakan
    [J]. EUROPEAN UROLOGY, 2008, 54 (02) : 362 - 370
  • [7] Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01-10.0 ng/ml)
    Caliskan, Selahattin
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 279 - 283
  • [8] Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
    Liu, Xin
    Tang, Jie
    Fei, Xiang
    Li, Qiu-Yang
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) : 1466 - 1472
  • [9] Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone
    Crawford, E. David
    Moul, Judd W.
    Rove, Kyle O.
    Pettaway, Curtis A.
    Lamerato, Lois E.
    Hughes, Alexa
    [J]. BJU INTERNATIONAL, 2011, 108 (11) : 1743 - 1749
  • [10] The Clinical Course of Patients With Prostate-Specific Antigen ≥100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening
    Leung, Andrew K.
    Hugar, Lee
    Patil, Dattatraya
    Wong, Lisa
    Carthon, Bradley
    Carney, K. Jeff
    Birdsong, George, II
    Moses, Kelvin A.
    Master, Viraj A.
    [J]. UROLOGY, 2018, 117 : 101 - 106
12345